Functional Endoscopic Sinus Surgery Study

Summary

Functional Endoscopic Sinus Surgery Study is a clinical trial^[1].

Key Facts

• Functional Endoscopic Sinus Surgery Study is in the country of United States^[2].
• Functional Endoscopic Sinus Surgery Study's instance of is recorded as clinical trial^[3].
• Functional Endoscopic Sinus Surgery Study's start time is recorded as +2019-07-31T00:00:00Z^[4].
• Functional Endoscopic Sinus Surgery Study's end time is recorded as +2021-07-31T00:00:00Z^[5].
• Functional Endoscopic Sinus Surgery Study's sponsor is recorded as University of Florida^[6].
• Functional Endoscopic Sinus Surgery Study's main subject is recorded as sinusitis^[7].
• Functional Endoscopic Sinus Surgery Study's number of participants is recorded as {'unit': '1', 'amount': '+40'}^[8].
• Functional Endoscopic Sinus Surgery Study's title is recorded as Does the Addition of Epinephrine to Bilateral Ultrasound Guided Pterygopalatine Ganglion Block Reduce Bleeding During Functional Endoscopic Sinus Surgery (FESS)? A Pilot Study^[9].
• Functional Endoscopic Sinus Surgery Study's short name is recorded as FESS^[10].
• Functional Endoscopic Sinus Surgery Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Functional Endoscopic Sinus Surgery Study's ClinicalTrials.gov ID is recorded as NCT03970655^[12].
• Functional Endoscopic Sinus Surgery Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+90'}^[13].
• Functional Endoscopic Sinus Surgery Study's research intervention is recorded as (±)-adrenaline^[14].
• Functional Endoscopic Sinus Surgery Study's clinical trial phase is recorded as phase I clinical trial^[15].
• Functional Endoscopic Sinus Surgery Study's clinical trial phase is recorded as phase II clinical trial^[16].
• Functional Endoscopic Sinus Surgery Study's study type is recorded as interventional study^[17].